市场资深人士Brandt预计,基于这些因素,Solana对ETH的价格将飙升100%

币界网Published on 2024-08-09Last updated on 2024-08-09

币界网报道:

资深分析师Peter Brandt认为,Solana可能会对以太坊飙升100%,并指出前者有多个有利因素。

Solana最近对以太坊的表现引发了包括Brandt在内的市场观察人士的反应。在最近的一项分析中,Brandt强调了Solana在对抗以太坊方面取得重大进展的潜力。

Solana的积累阶段

SOL/ETH周线图显示了从长期积累阶段的明显突破。这个持续了一年多的积累阶段以区间波动为特征,价格在大约0.0350到0.0500 ETH之间波动。

SOLETH 1W图表|彼得·勃兰特

突破发生在SOL飙升超过0.0500 ETH的关键阻力位时,该阻力位自2022年初以来一直是加密货币的上限。

市场分析师指出了这一突破的重要性。从历史上看,这种从长期积累阶段的突破往往会导致强劲的上涨,因为它们表明市场情绪的转变。

Solana瞄准以太坊100%上涨

成交量情况也支持了看涨前景,突破期间交易量显著增加。交易量的大幅飙升表明,突破可能会持续下去,因为这表明了强烈的购买兴趣。

在这些看涨走势中,有报道证实,巴西欢迎其首个现货Solana ETF产品。该报告引发Solana的价格飙升至163美元,有助于其对以太坊的收益。

此外,图表上的移动平均线(MA)进一步证实了看涨趋势。18周均线最近突破了8周均线,这是一个看涨的“黄金十字架”

下一个需要关注的关键水平是0.1100 ETH标记,它代表了基于前一个区间高度的潜在价格目标。如果SOL继续上涨,未来几个月可能会达到这一水平,这意味着从目前的价格水平上涨100%。

Brandt确定了支持Solana崛起的因素

除了技术方面,勃兰特对索拉纳的看涨前景还基于几个积极的基本面因素。首先,Brandt指出了以太坊持续存在的问题。他批评以太坊繁琐、“有缺陷”且昂贵。

据他说,以太坊关于去中心化的说法是有问题的。Brandt认为以太坊一直需要修复,这意味着它可能没有其支持者所认为的那么强大。他将以太坊对升级和改进的频繁需求与美国制造的汽车进行了比较。

另一方面,勃兰特称赞Solana用户友好,基础扎实。他强调,Solana的技术和基础设施更适合满足市场需求。

与此同时,在短期内,SOL/ETH比率昨日大幅飙升至0.0643的峰值。虽然这标志着其历史最高值,但索拉纳在这一水平上面临着强烈的阻力。因此,SOL最近对以太坊下跌,今天下跌了2.66%。

Trending Cryptos

Related Reads

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

On August 10, 2026, BPL (300246.SZ) resumed trading after a nearly week-long suspension and immediately fell by a 20% limit-down. This plunge was triggered by the termination of a planned controlling stake transfer, dashing earlier market speculation. In January 2026, Zhejiang Quwei Zhihe Partnership entered as a significant shareholder, sparking hopes. Investors speculated that its backer, Weigu Information—a specialized "little giant" company in high-reliability solid-state storage chips—might be seeking a backdoor listing through BPL. This "cross-industry restructuring" expectation fueled a strong rally, with BPL's stock price more than doubling in 2026 prior to the halt. However, the deal was called off on August 7, directly causing the sharp sell-off. Underlying BPL's vulnerability is its fundamentally weak business. The company, a medical device firm, is mired in losses, having reported three consecutive years of net losses totaling over 200 million yuan. Its core hemodialysis business is squeezed by government procurement price cuts, while growth in its patient monitor segment has stalled. Furthermore, BPL faces imminent debt pressure with convertible bonds worth approximately 218 million yuan due in September 2026, and its current stock price is far below the conversion price. The failed control transfer may represent a delayed release of negative news, but BPL's core challenges remain: reversing operational losses and addressing its urgent liquidity crisis.

marsbit2h ago

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

marsbit2h ago

Trading

Spot

Hot Articles

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of ETH (ETH) are presented below.

活动图片